Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Ethical and policy issues in newborn screening of children for neurologic and developmental disorders.

Ross LF.

Pediatr Clin North Am. 2015 Jun;62(3):787-98. doi: 10.1016/j.pcl.2015.03.009. Epub 2015 Apr 7. Review.

PMID:
26022175
2.
3.

Pediatricians' attitudes toward expanding newborn screening.

Acharya K, Ackerman PD, Ross LF.

Pediatrics. 2005 Oct;116(4):e476-84.

PMID:
16199673
4.

Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.

Hiraki S, Ormond KE, Kim K, Ross LF.

Am J Med Genet A. 2006 Nov 1;140(21):2312-9.

PMID:
17036312
5.

Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.

Bailey DB Jr, Skinner D, Davis AM, Whitmarsh I, Powell C.

Pediatrics. 2008 Mar;121(3):e693-704. doi: 10.1542/peds.2007-0820. Review.

PMID:
18310190
6.

Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.

Gatheridge MA, Kwon JM, Mendell JM, Scheuerbrandt G, Moat SJ, Eyskens F, Rockman-Greenberg C, Drousiotou A, Griggs RC.

JAMA Neurol. 2016 Jan;73(1):111-6. doi: 10.1001/jamaneurol.2015.3537. Review.

PMID:
26594870
7.

Predictive genetic testing for conditions that present in childhood.

Ross LF.

Kennedy Inst Ethics J. 2002 Sep;12(3):225-44.

PMID:
12472077
8.

Population-based testing: let's have population-based discussion.

Bonhomme N.

Genet Test Mol Biomarkers. 2013 Apr;17(4):265-6. doi: 10.1089/gtmb.2013.1543. No abstract available.

PMID:
23530538
9.

Newborn screening for Krabbe disease: the New York State model.

Duffner PK, Caggana M, Orsini JJ, Wenger DA, Patterson MC, Crosley CJ, Kurtzberg J, Arnold GL, Escolar ML, Adams DJ, Andriola MR, Aron AM, Ciafaloni E, Djukic A, Erbe RW, Galvin-Parton P, Helton LE, Kolodny EH, Kosofsky BE, Kronn DF, Kwon JM, Levy PA, Miller-Horn J, Naidich TP, Pellegrino JE, Provenzale JM, Rothman SJ, Wasserstein MP.

Pediatr Neurol. 2009 Apr;40(4):245-52; discussion 253-5. doi: 10.1016/j.pediatrneurol.2008.11.010.

PMID:
19302934
10.

Parental attitudes regarding newborn screening of PKU and DMD.

Campbell E, Ross LF.

Am J Med Genet A. 2003 Jul 15;120A(2):209-14.

PMID:
12833401
11.

Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.

Mendell JR, Lloyd-Puryear M.

Muscle Nerve. 2013 Jul;48(1):21-6. doi: 10.1002/mus.23810. Epub 2013 May 29.

PMID:
23716304
12.

Technical report: Ethical and policy issues in genetic testing and screening of children.

Ross LF, Saal HM, David KL, Anderson RR; American Academy of Pediatrics; American College of Medical Genetics and Genomics.

Genet Med. 2013 Mar;15(3):234-45. doi: 10.1038/gim.2012.176. Epub 2013 Feb 21. Erratum in: Genet Med. 2013 Apr;15(4):321. Ross, Laine Friedman [corrected to Ross, Lainie Friedman].

PMID:
23429433
13.

Newborn screening for fragile X syndrome.

Bailey DB Jr.

Ment Retard Dev Disabil Res Rev. 2004;10(1):3-10. Review.

PMID:
14994282
14.

Duchenne muscular dystrophy: issues in expanding newborn screening.

Kemper AR, Wake MA.

Curr Opin Pediatr. 2007 Dec;19(6):700-4. Review.

PMID:
18025940
15.

Weighing the evidence for newborn screening for early-infantile Krabbe disease.

Kemper AR, Knapp AA, Green NS, Comeau AM, Metterville DR, Perrin JM.

Genet Med. 2010 Sep;12(9):539-43. doi: 10.1097/GIM.0b013e3181e85721. Review.

PMID:
20601893
16.

Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.

Hinton CF, Grant AM, Grosse SD.

Ethn Health. 2011 Aug-Oct;16(4-5):377-88. doi: 10.1080/13557858.2010.541902.

PMID:
21797724
17.

Screening: Baby's first test.

Gupta S.

Nature. 2016 Sep 22;537(7621):S162-4. doi: 10.1038/537S162a. No abstract available.

PMID:
27652786
18.

Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).

Moat SJ, Bradley DM, Salmon R, Clarke A, Hartley L.

Eur J Hum Genet. 2013 Oct;21(10):1049-53. doi: 10.1038/ejhg.2012.301. Epub 2013 Jan 23.

19.

Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State.

Wasserstein MP, Andriola M, Arnold G, Aron A, Duffner P, Erbe RW, Escolar ML, Estrella L, Galvin-Parton P, Iglesias A, Kay DM, Kronn DF, Kurtzberg J, Kwon JM, Langan TJ, Levy PA, Naidich TP, Orsini JJ, Pellegrino JE, Provenzale JM, Wenger DA, Caggana M.

Genet Med. 2016 Dec;18(12):1235-1243. doi: 10.1038/gim.2016.35. Epub 2016 May 12.

PMID:
27171547
20.

A systematic review of population screening for fragile X syndrome.

Hill MK, Archibald AD, Cohen J, Metcalfe SA.

Genet Med. 2010 Jul;12(7):396-410. doi: 10.1097/GIM.0b013e3181e38fb6. Review.

PMID:
20548240

Supplemental Content

Support Center